facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
1/2018
vol. 105
 
Share:
Share:
abstract:
Special paper

Androgenetic alopecia. Diagnostic and therapeutic recommendations of the Polish Dermatological Society

Ligia Brzezińska-Wcisło
,
Adriana Rakowska
,
Lidia Rudnicka
,
Beata Bergler-Czop
,
Joanna Czuwara
,
Joanna Maj
,
Małgorzata Olszewska
,
Waldemar Placek
,
Adam Reich
,
Barbara Zegarska

Dermatol Rev/Przegl Dermatol 2018, 105, 1–18
Online publish date: 2018/03/12
View full text Get citation
 
PlumX metrics:
The main pathogenetic process in androgenetic alopecia is dihydrotestosterone-mediated follicular miniaturization in androgen-dependent scalp areas. Differential diagnosis is complex, especially in women, and covers a broad spectrum of non-cicatricial and cicatricial alopecias, particularly telogen effluvium and frontal fibrosing alopecia. The basic additional diagnostic procedure is trichoscopy. Currently there are two drugs approved for the treatment of androgenetic alopecia: minoxidil (in men and women) and finasteride (in men). However, medical literature indicates significantly more therapeutic options. The article presents algorithms recommended for the management of androgenetic alopecia in women and men.
keywords:

telogen effluvium, platelet-rich plasma, trichoscopy, spironolactone, shampoo



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.